RxDoctor Payments Data

Jeff Pavell, DO

Physical Medicine & Rehabilitation · Bardonia, NYNPI 1790769487

Payments from drug & device makers

$2,946in general payments, 2019–2025

Across 22 payments — averaging $133.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$2K
  • Fujifilm Sonosite, Inc.$600
  • Johnson & Johnson$95
  • Si-bone, Inc.$92
  • Stryker$80
  • SPR Therapeutics, Inc$72
  • plus $99 from 5 others

What the payments were for

  • Consulting fees$60020%
  • Food & beverage$47416%
  • Education$1,87264%

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,946 in reported general payments places this provider in the 85th percentile of 872 physical medicine & rehabilitation providers in New York.

See all physical medicine & rehabilitation providers in New York

Medicare billing

Part B allowed, 2024
$306,000
Medicare patients
371
Services billed
7,084

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate12$11,952
Oxycodone Hcl126$2,656
Gabapentin130$1,792
Diclofenac Sodium47$1,216
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen59$1,065
Pregabalin33$985
Morphine Sulfate ErMorphine Sulfate37$903
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen46$728
Fentanyl11$650
Baclofen31$606
Tizanidine Hcl33$417
Metaxalone12$326
Tramadol Hcl49$241
Duloxetine Hcl12$157
Meloxicam39$138

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er$12$11,95212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 872 physical medicine & rehabilitation providers in New York.

Other physical medicine & rehabilitation in Bardonia

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →